← Open Payments lookup

SREERAM GONNALAGADDA: Open Payments

NPI 1568520187 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,012 in 32 payments from 13 companies in 2025. Trend: 2023 $571 · 2024 $369 · 2025 $1,012

Food & beverage: $1,012
CompanyPaymentsAmount
Dexcom, Inc.4$313
Kowa Pharmaceuticals America, Inc.6$206
Amgen Inc.2$138
AstraZeneca Pharmaceuticals LP6$93
Abbott Laboratories4$79
PFIZER INC.2$39
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$32
Boehringer Ingelheim Pharmaceuticals, Inc.1$25
Xeris Pharmaceuticals, Inc.1$19
Exact Sciences Corporation1$19

Products named: DEXCOM G7 GSS (161), ZORYVE, Otezla, FREESTYLE LIBRE 3, XELJANZ, BREZTRI, CAPLYTA, FARXIGA.

Industry payments across TX — which companies pay providers there.